Ansseau, E.; Vanderplanck, C.; Wauters, A.; Harper, S.Q.; Coppée, F.; Belayew, A.
Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes 2017, 8, 93.
https://doi.org/10.3390/genes8030093
AMA Style
Ansseau E, Vanderplanck C, Wauters A, Harper SQ, Coppée F, Belayew A.
Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes. 2017; 8(3):93.
https://doi.org/10.3390/genes8030093
Chicago/Turabian Style
Ansseau, Eugénie, Céline Vanderplanck, Armelle Wauters, Scott Q. Harper, Frédérique Coppée, and Alexandra Belayew.
2017. "Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)" Genes 8, no. 3: 93.
https://doi.org/10.3390/genes8030093
APA Style
Ansseau, E., Vanderplanck, C., Wauters, A., Harper, S. Q., Coppée, F., & Belayew, A.
(2017). Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD). Genes, 8(3), 93.
https://doi.org/10.3390/genes8030093